Thermo Fisher Scientific Invests $25 Million to Support Black Communities and Businesses in the U.S.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has committed to investing up to $25 million in minority-serving financial institutions.

"Unequal access to capital is hurting Black-owned businesses, Black entrepreneurs and Black communities in the United States ," said Marc N. Casper , chairman, president and chief executive officer of Thermo Fisher Scientific. "Minority-serving financial institutions provide a bridge to empowering historically disenfranchised communities. For Thermo Fisher , supporting these institutions is part of our commitment to addressing inequalities through our business and hiring practices."

The company has committed $20 million to the Black Economic Development Fund (BEDF), which was launched by the Local Initiatives Support Corporation (LISC) to increase financing to Black-led financial institutions, anchor institutions, and businesses. LISC is one of the nation's oldest and largest Community Development Financial Institutions (CDFIs) and has invested more than $22 billion to expand economic opportunity in nearly every state.

"We know from experience that when investments address racial disparities in health, wealth and opportunity, they also help fuel lasting economic growth," said George Ashton , president of LISC Fund Management, LLC, which oversees the BEDF. "Forward-looking companies like Thermo Fisher are making impact investments that break down barriers and bridge capital gaps for Black businesses, which ultimately helps our economy work better for everyone."

In addition, Thermo Fisher will deposit $5 million in Hope Credit Union's Transformational Deposits program. Hope Credit Union seeks to provide financing to low-wealth families, people of color and financially underserved communities to finance small businesses, housing, healthcare and other vital needs.  HOPE uses Transformational Deposits to import the capital needed to increase economic opportunities for individuals and families across five Deep South states ( Mississippi , Alabama , Arkansas , Tennessee , and Louisiana ).

"Investments in Black owned financial institutions are a proven way to advance economic mobility," said Bill Bynum , chief executive officer, Hope Credit Union . "Black owned financial institutions are more likely to lend to businesses, support employment and locate in Black communities. Thermo Fisher's Transformational Deposit is an important step towards closing the racial wealth gap."

In addition to these investments, in August 2020 Thermo Fisher launched "The Just Project" with a donation of $25 million in diagnostic instruments, test kits and related supplies to support the safe reopening of historically black colleges and universities (HBCUs) in the U.S. The company also announced that it is committed to hiring at least 500 students from HBCUs over the next three years.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion . Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com .

About LISC
Together with residents and partners, LISC help forge resilient and inclusive communities of opportunity across America – great places to live, work, visit, do business and raise families. Since 1979, LISC has invested more than $22 billion to build or rehab more than 419,000 affordable homes and apartments and develop 70.3 million square feet of retail, community and educational space. LISC Fund Management, LLC, a LISC affiliate, creates and manages mission-driven investment vehicles on behalf of investors and funders to drive equitable growth across the US. For more information about LISC, please visit www.lisc.org . For more information about LISC Fund Management, LLC please visit liscstrategicinvestments.org/fund-management .

About BEDF Fund
The Black Economic Development Fund (BEDF) is an impact investment fund built to address economic challenges in Black communities and to help close the racial wealth gap. The fund targets Black-led financial institutions, businesses and anchor institutions with the goal of growing these organizations and strengthening their contributions to Black communities. The funddeploys capital across a diverse set of industries, borrowers and geographies in the US. The BEDF is managed by the LISC Strategic Investments team and the LISC Fund Management, LLC, a LISC affiliate.

For more information on the BEDF, please visit https://www.liscstrategicinvestments.org/black-economic-development-fund .

Thermo Fisher Scientific (PRNewsfoto/Thermo Fisher Scientific)

Media Contact Information:
Charlotte McCormack
Phone: 781-622-1202
E-mail: charlotte.mccormack@thermofisher.com

Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: ken.apicerno@thermofisher.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-invests-25-million-to-support-black-communities-and-businesses-in-the-us-301226753.html

SOURCE Thermo Fisher Scientific

News Provided by PR Newswire via QuoteMedia

The Conversation (0)

Bausch Health to Announce First-Quarter 2024 Results on May 2

Bausch Health Companies Inc. (NYSE:NHC)(TSX:BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call

Conference Call Details

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that the U.S. Court of Appeals for the Federal Circuit in the matter of Salix Pharmaceuticals, LTD. et al v. Norwich Pharmaceuticals, Inc., affirmed the May 17, 2023 decision of the U.S. District Court for the District of Delaware that had denied Norwich Pharmaceuticals, Inc.'s motion for modification of the court's final order preventing the U.S. Food and Drug Administration (FDA) from approving its abbreviated new drug application (ANDA) for XIFAXAN (rifaximin) 550 mg before Oct. 2, 2029. The Court of Appeals also affirmed the August 10, 2022 decision of the District Court that invalidated certain U.S. Patents protecting the composition and use of XIFAXAN® for treating IBS-D. As a result of the Federal Circuit's decision, Norwich's abbreviated new drug application for XIFAXAN (rifaximin) 550 mg remains barred from approval by the U.S. Food and Drug Administration until Oct. 2, 2029

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Acne Vulgaris Treatment PrARAZLO Now Available to Patients Through British Columbia PharmaCare Public Drug Plan

Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescription treatment for acne vulgaris, PrARAZLOTM (tazarotene lotion, 0.045% ww), is now available to patients through BC PharmaCare, the public drug program of British Columbia

ARAZLO is the only tazarotene lotion treatment approved by Health Canada for the topical treatment of acne vulgaris in patients 10 years of age and older.1 The listing by BC PharmaCare means ARAZLO is now available to patients on all public drug plans across Canada.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Cleo Diagnostics

CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials

Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research Organization (CRO), Lindus Health, as a key partner for its U.S. clinical trials program.

Keep reading...Show less

Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024, at 10:30 a.m. ET at the Metro Toronto Convention Centre in Toronto. A copy of the presentation will be available at www.knighttx.com .

About Knight Therapeutics Inc.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
{{ sections }}

Latest Press Releases

Related News

×